Become A Featured Company

DigiPath’s Dr. Cindy Orser Speaks On Cannabis Standards

Ryan Allway

August 5th, 2014

Uncategorized

DigiPath, Inc. (OTCBB and OTCQB: DIGP), a digital pathology solution provider that is rapidly expanding into the cannabis testing and education markets, announced today that Cindy Orser, Ph.D. will lead an introductory webinar on the importance of standards in the cannabis industry on Thursday, August 14, 2014. The key issue of adopting standards is the second in a five-week series of webinars collectively titled: “Cannabis 2.0: Making It in the Emerging Marijuana Industry,” which begins on August 7th.

As Chief Science Officer at DigiPath, Dr. Orser is creating a replicable testing environment with validated protocols to ensure cannabis and cannabis-based products are safe. She will also be developing standards and biomarkers to clearly distinguish products derived from specific cannabis strains concomitant with determining the bioavailability of the cannabinoids found in the product.

A serial entrepreneur, Dr. Orser has launched five small biotech ventures during the last ten years. These ventures include Big Sky Biosystems Inc., which offers scientific, technical, regulatory and strategic affairs consulting to the molecular and medical diagnostics industry, and CB Cures LLC, which was working to develop novel formulations of cannabis extracts for clinical endpoints and a THC biosensor for roadside sobriety testing.

During her hour-long presentation, Dr. Orser will discuss how the chemical composition of each strain of cannabis varies, and how each plant’s cannabinoid and terpenoid profiles may be beneficial in relieving symptoms associated with chronic disease. She will also examine the need for setting industry standards and processes for cultivating cannabis, converting cannabis to cannabis-based products, and testing cannabis and cannabis-based products.

“Many people are looking for an opportunity to benefit from a wave of recent legal victories in the cannabis market, but most people don’t know what to do,” said Mike “Zappy” Zapolin, Cannabis 2.0’s host and moderator of this year’s Milken Global Conference panel titled The Highs and Lows of the Cannabis Economy. “This course gives them the tools they need to immediately jump in and be successful.”

Zapolin points out that for the majority of the last century, prohibition kept cannabis underground, but now, the industry is shifting away from people who were willing to break the law and sell drugs for cash to licensed companies with banking relationships and publicly traded stocks. And it’s not just entrepreneurs—scientists, doctors, and seasoned business executives are increasingly entering the industry as cannabis commerce relocates from dark alleyways to Main Street.

“Dr. Orser’s webinar is a great way for people to meet her and learn about our work to improve the cannabis industry,” said Steve Barbee, CEO of DigiPath, Inc. “We strongly believe education holds the key to its transformation, and we are set to lead the industry on that front.”

For more information about the series, go to: http://evolverlearninglab.com/products/cannabis-2-0-making-it-in-the-emerging-marijuana-industry.

About DigiPath, Inc.

DigiPath, Inc., develops and markets affordable and accurate human and animal digital pathology solutions. The company is rapidly expanding into the botanical, nutraceutical, and cannabis industries with industry-leading testing, and education and training services.

For more information, go to: www.digipath.com and www.digipath.biz.

Information about Forward-Looking Statements

This press release contains “forward-looking statements” that include information relating to future events and future financial and operating performance. The words “may,” “might,” “would,” “will,” “expect,” “estimate,” “can,” “believe,” “potential” and similar expressions and variations thereof are intended to identify forward-looking statements. Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management’s good faith belief as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. Important factors that could cause these differences include, but are not limited to: fluctuations in demand for the Company’s products, the introduction of new products, the Company’s ability to maintain customer and strategic business relationships, the impact of competitive products and pricing, growth in targeted markets, the adequacy of the Company’s liquidity and financial strength to support its growth, and other information that may be detailed from time-to-time in the Company’s filings with the United States Securities and Exchange Commission. An example of such forward looking statements in this press release include statements regarding the Company developing and completing new products and revenue growth. For a more detailed description of the risk factors and uncertainties affecting DigiPath, please refer to the Company’s recent Securities and Exchange Commission filings, which are available at www.sec.gov. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Disclaimer: Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. Emerging Growth LLC dba TDM Financial, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Network Partners

Follow Us on Social Media

LinkedIn

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading